ROSEN, LEADING INVESTOR COUNSEL, Encourages Soleno Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - SLNO
newsfilecorp.com
Want to monitor 7317.T?
Get notified when price crosses targets, volume spikes, or RSI hits oversold
Create free account to monitor 7317.TNo data available
No company information available